P18461
Gene name |
FGFR2 (CEK3) |
Protein name |
Fibroblast growth factor receptor 2 |
Names |
FGFR-2 , EC 2.7.10.1 , Tyrosine kinase receptor CEK3 |
Species |
Gallus gallus (Chicken) |
KEGG Pathway |
gga:396259 |
EC number |
2.7.10.1: Protein-tyrosine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
25-129 (D2 domain) |
Relief mechanism |
Others |
Assay |
|
Target domain |
483-770 (Protein kinase domain) |
Relief mechanism |
Ligand binding, PTM |
Assay |
|
Target domain |
483-770 (Protein kinase domain) |
Relief mechanism |
Ligand binding, PTM |
Assay |
|
Accessory elements
645-670 (Activation loop from InterPro)
Target domain |
483-772 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
645-670 (Activation loop from InterPro)
Target domain |
483-772 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Lew ED et al. (2007) "Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation", Proceedings of the National Academy of Sciences of the United States of America, 104, 19802-7
- Kalinina J et al. (2012) "The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition", Structure (London, England : 1993), 20, 77-88
- Uchikawa E et al. (2019) "Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex", eLife, 8,
- Nielsen J et al. (2022) "Structural Investigations of Full-Length Insulin Receptor Dynamics and Signalling", Journal of molecular biology, 434, 167458
- Chen YS et al. (2021) "Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation", Proceedings of the National Academy of Sciences of the United States of America, 118,
- Craddock BP et al. (2007) "Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region", FEBS letters, 581, 3235-40
- Klein T et al. (2015) "Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinase", Nature communications, 6, 7877
- Huang X et al. (2009) "Structural insights into the inhibited states of the Mer receptor tyrosine kinase", Journal of structural biology, 165, 88-96
- Olsen SK et al. (2004) "Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity", Proceedings of the National Academy of Sciences of the United States of America, 101, 935-40
- Knowles PP et al. (2006) "Structure and chemical inhibition of the RET tyrosine kinase domain", The Journal of biological chemistry, 281, 33577-87
Autoinhibited structure

Activated structure

1 structures for P18461
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P18461-F1 | Predicted | AlphaFoldDB |
No variants for P18461
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for P18461 |
No associated diseases with P18461
15 regional properties for P18461
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 483 - 772 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 483 - 759 | IPR001245 |
domain | Immunoglobulin subtype 2 | 56 - 117 | IPR003598-1 |
domain | Immunoglobulin subtype 2 | 172 - 240 | IPR003598-2 |
domain | Immunoglobulin subtype 2 | 271 - 351 | IPR003598-3 |
domain | Immunoglobulin subtype | 50 - 128 | IPR003599-1 |
domain | Immunoglobulin subtype | 166 - 251 | IPR003599-2 |
domain | Immunoglobulin subtype | 265 - 362 | IPR003599-3 |
domain | Immunoglobulin-like domain | 42 - 128 | IPR007110-1 |
domain | Immunoglobulin-like domain | 156 - 249 | IPR007110-2 |
domain | Immunoglobulin-like domain | 258 - 360 | IPR007110-3 |
active_site | Tyrosine-protein kinase, active site | 624 - 636 | IPR008266 |
domain | Immunoglobulin I-set | 173 - 250 | IPR013098 |
binding_site | Protein kinase, ATP binding site | 489 - 519 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 483 - 759 | IPR020635 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.1 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
4 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasmic vesicle | A vesicle found in the cytoplasm of a cell. |
Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
receptor complex | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
3 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
fibroblast growth factor binding | Binding to a fibroblast growth factor. |
fibroblast growth factor receptor activity | Combining with a fibroblast growth factor receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
3 GO annotations of biological process
Name | Definition |
---|---|
apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
76 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P43481 | KIT | Mast/stem cell growth factor receptor Kit | Bos taurus (Bovine) | SS |
Q06805 | TIE1 | Tyrosine-protein kinase receptor Tie-1 | Bos taurus (Bovine) | PR |
Q06807 | TEK | Angiopoietin-1 receptor | Bos taurus (Bovine) | SS |
Q28889 | KIT | Mast/stem cell growth factor receptor Kit | Felis catus (Cat) (Felis silvestris catus) | SS |
P13369 | CSF1R | Macrophage colony-stimulating factor 1 receptor | Felis catus (Cat) (Felis silvestris catus) | SS |
P18460 | FGFR3 | Fibroblast growth factor receptor 3 | Gallus gallus (Chicken) | SS |
P21804 | FGFR1 | Fibroblast growth factor receptor 1 | Gallus gallus (Chicken) | SS |
Q08156 | KIT | Mast/stem cell growth factor receptor Kit | Gallus gallus (Chicken) | SS |
Q8AXY6 | MUSK | Muscle, skeletal receptor tyrosine protein kinase | Gallus gallus (Chicken) | SS |
Q5F3X2 | DDR1 | receptor protein-tyrosine kinase | Gallus gallus (Chicken) | SS |
Q91987 | NTRK2 | BDNF/NT-3 growth factors receptor | Gallus gallus (Chicken) | SS |
Q91044 | NTRK3 | NT-3 growth factor receptor | Gallus gallus (Chicken) | SS |
Q8QHL3 | FLT1 | Vascular endothelial growth factor receptor 1 | Gallus gallus (Chicken) | SS |
Q98949 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | Gallus gallus (Chicken) | PR |
Q9PUF6 | PDGFRA | Platelet-derived growth factor receptor alpha | Gallus gallus (Chicken) | SS |
Q91009 | NTRK1 | High affinity nerve growth factor receptor | Gallus gallus (Chicken) | SS |
Q07494 | EPHB1 | Ephrin type-B receptor 1 | Gallus gallus (Chicken) | SS |
Q07407 | htl | Fibroblast growth factor receptor homolog 1 | Drosophila melanogaster (Fruit fly) | PR |
Q6J9G0 | STYK1 | Tyrosine-protein kinase STYK1 | Homo sapiens (Human) | PR |
P36888 | FLT3 | Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (Human) | EV |
P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Homo sapiens (Human) | EV |
P09619 | PDGFRB | Platelet-derived growth factor receptor beta | Homo sapiens (Human) | EV |
P35916 | FLT4 | Vascular endothelial growth factor receptor 3 | Homo sapiens (Human) | SS |
P35968 | KDR | Vascular endothelial growth factor receptor 2 | Homo sapiens (Human) | EV |
P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | Homo sapiens (Human) | SS |
P07333 | CSF1R | Macrophage colony-stimulating factor 1 receptor | Homo sapiens (Human) | SS |
P10721 | KIT | Mast/stem cell growth factor receptor Kit | Homo sapiens (Human) | EV |
P07949 | RET | Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (Human) | EV |
P35590 | TIE1 | Tyrosine-protein kinase receptor Tie-1 | Homo sapiens (Human) | PR |
Q02763 | TEK | Angiopoietin-1 receptor | Homo sapiens (Human) | SS |
P11362 | FGFR1 | Fibroblast growth factor receptor 1 | Homo sapiens (Human) | EV |
P22455 | FGFR4 | Fibroblast growth factor receptor 4 | Homo sapiens (Human) | SS |
P22607 | FGFR3 | Fibroblast growth factor receptor 3 | Homo sapiens (Human) | EV |
P21802 | FGFR2 | Fibroblast growth factor receptor 2 | Homo sapiens (Human) | EV |
Q03142 | Fgfr4 | Fibroblast growth factor receptor 4 | Mus musculus (Mouse) | PR |
P05532 | Kit | Mast/stem cell growth factor receptor Kit | Mus musculus (Mouse) | PR |
Q91V87 | Fgfrl1 | Fibroblast growth factor receptor-like 1 | Mus musculus (Mouse) | PR |
P35917 | Flt4 | Vascular endothelial growth factor receptor 3 | Mus musculus (Mouse) | SS |
P05622 | Pdgfrb | Platelet-derived growth factor receptor beta | Mus musculus (Mouse) | SS |
P09581 | Csf1r | Macrophage colony-stimulating factor 1 receptor | Mus musculus (Mouse) | SS |
P35969 | Flt1 | Vascular endothelial growth factor receptor 1 | Mus musculus (Mouse) | SS |
P35546 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Mus musculus (Mouse) | SS |
Q06806 | Tie1 | Tyrosine-protein kinase receptor Tie-1 | Mus musculus (Mouse) | SS |
Q00342 | Flt3 | Receptor-type tyrosine-protein kinase FLT3 | Mus musculus (Mouse) | SS |
Q6J9G1 | Styk1 | Tyrosine-protein kinase STYK1 | Mus musculus (Mouse) | PR |
Q61851 | Fgfr3 | Fibroblast growth factor receptor 3 | Mus musculus (Mouse) | PR |
Q02858 | Tek | Angiopoietin-1 receptor | Mus musculus (Mouse) | SS |
P35918 | Kdr | Vascular endothelial growth factor receptor 2 | Mus musculus (Mouse) | PR |
P26618 | Pdgfra | Platelet-derived growth factor receptor alpha | Mus musculus (Mouse) | SS |
P16092 | Fgfr1 | Fibroblast growth factor receptor 1 | Mus musculus (Mouse) | SS |
P21803 | Fgfr2 | Fibroblast growth factor receptor 2 | Mus musculus (Mouse) | SS |
Q2HWD6 | KIT | Mast/stem cell growth factor receptor Kit | Sus scrofa (Pig) | SS |
Q7TQM3 | Fgfrl1 | Fibroblast growth factor receptor-like 1 | Rattus norvegicus (Rat) | PR |
P53767 | Flt1 | Vascular endothelial growth factor receptor 1 | Rattus norvegicus (Rat) | PR |
P20786 | Pdgfra | Platelet-derived growth factor receptor alpha | Rattus norvegicus (Rat) | SS |
Q91ZT1 | Flt4 | Vascular endothelial growth factor receptor 3 | Rattus norvegicus (Rat) | SS |
Q04589 | Fgfr1 | Fibroblast growth factor receptor 1 | Rattus norvegicus (Rat) | SS |
G3V9H8 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Rattus norvegicus (Rat) | SS |
Q05030 | Pdgfrb | Platelet-derived growth factor receptor beta | Rattus norvegicus (Rat) | SS |
O08775 | Kdr | Vascular endothelial growth factor receptor 2 | Rattus norvegicus (Rat) | SS |
Q498D6 | Fgfr4 | Fibroblast growth factor receptor 4 | Rattus norvegicus (Rat) | PR |
Q17833 | old-1 | Tyrosine-protein kinase receptor old-1 | Caenorhabditis elegans | PR |
Q19238 | F09A5.2 | Putative tyrosine-protein kinase F09A5.2 | Caenorhabditis elegans | SS |
P34892 | kin-16 | Receptor-like tyrosine-protein kinase kin-16 | Caenorhabditis elegans | PR |
G5ED65 | ver-1 | Protein ver-1 | Caenorhabditis elegans | PR |
Q10656 | egl-15 | Myoblast growth factor receptor egl-15 | Caenorhabditis elegans | PR |
Q8AXB3 | kdrl | Vascular endothelial growth factor receptor kdr-like | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q5GIT4 | kdr | Vascular endothelial growth factor receptor 2 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
O73791 | tek | Angiopoietin-1 receptor | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q9I8N6 | csf1r | Macrophage colony-stimulating factor 1 receptor | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q90413 | fgfr4 | Fibroblast growth factor receptor 4 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q9DE49 | pdgfra | Platelet-derived growth factor receptor alpha | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q8JFR5 | kita | Mast/stem cell growth factor receptor kita | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q5MD89 | flt4 | Vascular endothelial growth factor receptor 3 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q90Z00 | fgfr1a | Fibroblast growth factor receptor 1-A | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q8JG38 | fgfr2 | Fibroblast growth factor receptor 2 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MVSWDSGCLI | CLVVVTMAGL | SLARPSFNLV | VEDATLEPEE | PPTKYQISQP | DVHSALPGEP |
70 | 80 | 90 | 100 | 110 | 120 |
LELRCQLKDA | VMISWTKDGV | PLGPDNRTVI | IGEYLQIKDA | SPRDSGLYAC | TAIRTLDSDT |
130 | 140 | 150 | 160 | 170 | 180 |
LYFIVNVTDA | LSSGDDEDDN | DGSEDFVNDS | NQMRAPYWTH | TDKMEKRLHA | VPAANTVKFR |
190 | 200 | 210 | 220 | 230 | 240 |
CPAMGNPTPT | MRWLKNGKEF | KQEHRIGGYK | VRNQHWSLIM | ESVVPSDKGN | YTCIVENQYG |
250 | 260 | 270 | 280 | 290 | 300 |
SINHTYHLDV | VERSPHRPIL | QAGLPANASA | VVGGDVEFVC | KVYSDAQPHI | QWIKHVERNG |
310 | 320 | 330 | 340 | 350 | 360 |
SKYGPDGLPY | LQVLKAAGVN | TTDKEIEVLY | IRNVTFEDAG | EYTCLAGNSI | GISFHTAWLT |
370 | 380 | 390 | 400 | 410 | 420 |
VLPAPEKEKE | FPTSPDYLEI | AIYCIGVFLI | ACMVLTVILC | RMKNTTKKPD | FSSQPAVHKL |
430 | 440 | 450 | 460 | 470 | 480 |
TKRIPLRRQV | TVSADSSSSM | NSNTPLVRIT | TRLSSTADAP | MLAGVSEYEL | PEDPKWEFPR |
490 | 500 | 510 | 520 | 530 | 540 |
DKLTLGKPLG | EGCFGQVVMA | EAVGIDKDRP | KEAVTVAVKM | LKDDATEKDL | SDLVSEMEMM |
550 | 560 | 570 | 580 | 590 | 600 |
KMIGKHKNII | NLLGACTQDG | PLYVIVEYAS | KGNLREYLRA | RRPPGMEYSF | DINRVPEEQM |
610 | 620 | 630 | 640 | 650 | 660 |
TFKDLVSCTY | QLARGMEYLA | SQKCIHRDLA | ARNVLVTENN | VMKIADFGLA | RDINNIDYYK |
670 | 680 | 690 | 700 | 710 | 720 |
KTTNGRLPVK | WMAPEALFDR | VYTHQSDVWS | FGVLMWEIFT | LGGSPYPGIP | VEELFKLLKE |
730 | 740 | 750 | 760 | 770 | 780 |
GHRMDKPANC | TNELYMMMRD | CWQAVPSQRP | TFKQLVEDLD | RILTLTTNEE | YLDLSGPLEQ |
790 | 800 | 810 | 820 | ||
YSPSYPDTRS | SCSSGDDSVF | SPDPMPYEPC | LPKYQHMNGS | VKT |